RPG Life Sciences Ltd.

2,161.6

2.5 (0.1%)growUp

As on June 5, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap3,602 Cr
P/E Ratio19.51
Dividend Yield0.14 %
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock_ipo_icon.webpUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open2,161
High2,184.7
NSE SymbolRPGLIFE
Close2,161.6
Low2,100
BSE Symbol532983
Previous Years High/Low
1 Year High2,725
3 Year High2,974.95
5 Year High2,974.95
1 Year Low1,733
3 Year Low790
5 Year Low424.85

Technicals


IndicatorsValueSignal
5-DMA2,176.8Bearish
10-DMA2,210.26Bearish
20-DMA2,271.13Bearish
50-DMA2,108.8Bullish
100-DMA2,064.19Bullish
200-DMA2,195.51Bearish

Historical Performance


1 Year
-0.4%
3 Years
171.2%
5 Years
390.8%
10 Years
760.5%

Shareholding Pattern


%

Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


Compounded Sales Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Compounded Profit Growth
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Stock Price CAGR
10 Years:24.1
5 Years:37.5
3 Years:39.5
TTM:0.9
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:N/A

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a moderate PE of 19.51, suggesting fair valuation relative to earnings.
  • Over the last three years, the stock delivered a strong 3-year price CAGR of 39.5%, indicating sustained price appreciation.
  • The stock carries a beta of 0.8, indicating volatility broadly in line with the market.
  • In the last financial year, the company reported an EBITDA of ₹1733 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹6534 million, suggesting a mid-sized operation.

Investment Calculator


Investment Amount: ₹ 1000000
Current Value: ₹ 1009291.7
No. of Shares: 467 (Approx)
Performance:0.9%
P/L: ₹9291.7
NIFTY Performance: -6.5%
1 day Top Gainers
SymbolChange%
ZEEL112.27(8%)
ADANIGREEN1525.7(7%)
HSCL685.05(7%)
JYOTICNC634.3(6%)
SCHNEIDER1172.2(6%)
1 Day Top Losers
SymbolChange%
WOCKPHARMA1920.9(-7%)
HINDZINC566.8(-6%)
NETWEB4666(-5%)
HFCL187.23(-5%)
NATIONALUM395.7(-4%)
TEJASNET576.2(-4%)
BSE3880(-4%)
VEDL315.6(-4%)

Top Performing Stocks from the same sector


Venus Remedies Ltd.

72%

1633.5

1 Month Performance

Bliss GVS Pharma Ltd.

62.5%

438.35

1 Month Performance

Sun Pharma Advanced Research Company Ltd.

52%

212.82

1 Month Performance

Panacea Biotec Ltd.

45.7%

540.2

1 Month Performance

IOL Chemicals And Pharmaceuticals Ltd.

39.2%

131.68

1 Month Performance

Supriya Lifescience Ltd.

37.2%

947.95

1 Month Performance

Orchid Pharma Ltd.

34.6%

844.25

1 Month Performance

Novartis India Ltd.

34.2%

1391.1

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month